BioConsortia
Davis, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into BioConsortia
Sign up to see every warm intro you have to BioConsortia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioConsortia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioConsortia discovers and develops microbial biological products for agriculture, using microbial engineering and field validation to create seed-applied and soil-directed solutions that enhance crop productivity and sustainability. The company serves global agriculture stakeholders seeking biological alternatives to synthetic inputs.
Founders & leadership
Board
Investors · 1
How we know: a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$41M disclosed across 4 of 6 rounds · 2016–2025
▶$15MraisedApr 2023 · 1 investors · OtherRule 506(b)
- Marcus Meadows-SmithExecutive Officer, Director
- Christina HubenExecutive Officer
- John M. PasquesiDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedMar 2019 · 3 investors · OtherRule 506(b)
- Christina E. HubenExecutive Officer
- Marcus Meadows-SmithExecutive Officer, Director
- John M. PasquesiDirector
- Offering amount
- $8M
- Amount sold
- $8M
- Minimum investment
- $90.1K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedMar 2018 · 3 investors · OtherRule 506(b)
- John M. PasquesiDirector
- Christina E. HubenExecutive Officer
- Marcus Meadows-SmithExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $150.2K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$8MraisedOct 2016 · 5 investors · OtherRule 506(b)
- John M. PasquesiDirector
- Christina E. HubenExecutive Officer
- Tamara TompkinsDirector
- Marcus Meadows-SmithExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $8M
- Minimum investment
- $107.7K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as BioConsortia.
In the news
Frequently asked questions
- What does BioConsortia do?
- BioConsortia discovers and develops microbial biological products for agriculture, using microbial engineering and field validation to create seed-applied and soil-directed solutions that enhance crop productivity and sustainability. The company serves global agriculture stakeholders seeking biological alternatives to synthetic inputs.
- Who are BioConsortia's investors?
- BioConsortia's investors include Khosla Ventures.
- How much funding has BioConsortia raised?
- BioConsortia has disclosed $41M raised across 4 of its 6 known rounds.
- Where is BioConsortia headquartered?
- BioConsortia is headquartered in Davis, US.


